This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.
This report summarises key issues related to HIV and people who inject drugs in Europe and Central Asia based on data provided by countries for reporting on the Dublin Declaration in 2018.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 14-24 August 2019 and includes updates on Ebola virus disease in the Democratic Republic of the Congo, monitoring environmental sustainability of Vibrio growth in the Baltic Sea, West Nile virus infection, haemorrhagic fever with renal syndrome in Croatia and Slovenia, the mass gathering of the Hajj in Saudi Arabia and Listeriosis in Spain. (Erratum (26 August 2019): On pages 2 and 5 (West Nile virus infection), the figure of eight deaths in Greece (4), Cyprus (1) and Serbia (1) has been amended to four deaths in Greece (2), Cyprus (1) and Serbia (1)